Diane C. Young insider trades: Celldex Therapeutics (CLDX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Diane reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | CLDX | ↓ Sell | 45,000 | $35.26 | $1.6M | Direct | Jun 11, 2024 (4d) |
| Aug 17, 2022 | CLDX | ↓ Sell | 19,000 | $37.30 | $709K | Direct | Aug 19, 2022 (2d) |
| Nov 12, 2021 | CLDX | ↓ Sell | 4,600 | $42.94 | $198K | Direct | Nov 16, 2021 (4d) |
| Jun 11, 2020 | CLDX | ↑ Buy | 2,115 | $4.73 | $10K | Direct | Jun 12, 2020 (1d) |
| Jul 16, 2018 | GTXI | ↓ Sell | 2,049 | $14.70 | $30K | Direct | Jul 17, 2018 (1d) |
| Oct 28, 2016 | GTXI | ↓ Sell | 500 | $7.70 | $4K | By Spouse | Feb 28, 2017 (123d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CLDX insiders
Open-market trades in the last 12 months
About Diane C. Young's insider trades
Diane C. Young is SVP, Chief Medical Officer at Celldex Therapeutics (CLDX). Since Oct 28, 2016, Diane has reported 1 open-market purchase worth $10K and 5 sales worth $2.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), option exercises (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.